Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Evolving Tactics With Inhibition of Sodium-Glucose Cotransporters

  • Evolving Tactics With Inhibition of Sodium-Glucose Cotransporters
  • You have access
    Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
    Julio Rosenstock, William T. Cefalu, Pablo Lapuerta, Brian Zambrowicz, Ike Ogbaa, Phillip Banks, Arthur Sands
    Diabetes Care Mar 2015, 38 (3) 431-438; DOI: 10.2337/dc14-0890
  • Open Access
    Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
    Colleen Majewski, George L. Bakris
    Diabetes Care Mar 2015, 38 (3) 429-430; DOI: 10.2337/dc14-1596
  • Open Access
    Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
    Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra Green, Afshin Salsali, Uli C. Broedl, Hans J. Woerle
    Diabetes Care Mar 2015, 38 (3) 420-428; DOI: 10.2337/dc14-1096
  • You have access
    Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Robert R. Henry, Julio Rosenstock, Steven Edelman, Sunder Mudaliar, Alexandros-Georgios Chalamandaris, Sreeneeranj Kasichayanula, Allyson Bogle, Nayyar Iqbal, James List, Steven C. Griffen
    Diabetes Care Mar 2015, 38 (3) 412-419; DOI: 10.2337/dc13-2955
  • You have access
    Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
    Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Kirk Ways, Mehul Desai, Wayne Shaw, George Capuano, Maria Alba, Joel Jiang, Frank Vercruysse, Gary Meininger, David Matthews
    Diabetes Care Mar 2015, 38 (3) 403-411; DOI: 10.2337/dc14-1237
  • You have access
    Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
    Andrew Lewin, Ralph A. DeFronzo, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
    Diabetes Care Mar 2015, 38 (3) 394-402; DOI: 10.2337/dc14-2365
  • You have access
    Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
    Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
    Diabetes Care Mar 2015, 38 (3) 384-393; DOI: 10.2337/dc14-2364
  • Open Access
    Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
    Julio Rosenstock, Lars Hansen, Pamela Zee, Yan Li, William Cook, Boaz Hirshberg, Nayyar Iqbal
    Diabetes Care Mar 2015, 38 (3) 376-383; DOI: 10.2337/dc14-1142
  • Open Access
    Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?
    Muhammad Abdul-Ghani
    Diabetes Care Mar 2015, 38 (3) 373-375; DOI: 10.2337/dc14-2517
  • You have access
    Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial
    Stephan Matthaei, Keith Bowering, Katja Rohwedder, Anke Grohl, Shamik Parikh
    Diabetes Care Mar 2015, 38 (3) 365-372; DOI: 10.2337/dc14-0666

Pages

  • Next
  • 1
  • 2
  • ADA Position Statements (17)
  • Advances in Artificial Pancreas Development (8)
  • Blood Pressure Targets and Type 2 Diabetes (7)
  • Cardiovascular Disease and Diabetes (11)
  • Clinical Therapeutics/New Technology-Glucose Monitoring and Sensing (97)
  • Clinical Therapeutics/New Technology-Insulin Delivery Systems (42)
  • Clinical Therapeutics/New Technology-Insulins (53)
  • Clinical Therapeutics/New Technology-Non-Insulin Injectables (50)
  • Clinical Therapeutics/New Technology-Oral Agents (139)
  • Clinical Therapeutics/New Technology-Pharmacological Treatment of Complications (37)
  • Complications-Hypoglycemia (64)
  • Complications-Macrovascular-Atherosclerotic Cardiovascular Disease and Human Diabetes (197)
  • Complications-Macrovascular-Cellular Mechanisms of Atherogenesis in Diabetes (12)
  • Complications-Nephropathy-Basic and Experimental Science (31)
  • Complications-Nephropathy-Clinical and Translational Research (91)
  • Complications-Neuropathy (52)
  • Complications-Retinopathy (64)
  • Considerations in the Management of Gestational Diabetes Mellitus (10)
  • Continuous Glucose Monitoring and Risk of Hypoglycemia (8)
  • Continuous Glucose Monitoring for Type 1 Diabetes (8)
  • COVID-19 and Diabetes Patient Care (5)
  • Critical Review of the Risks and Benefits of New Therapies (5)
  • Current Concepts of Type 2 Diabetes Prevention (8)
  • DCCT/EDIC 30th Anniversary Summary Findings (8)
  • Diabetes and COVID-19 (94)
  • Diabetes and COVID-19 Articles (16)
  • Diabetes Care Expert Forum (6)
  • Diabetes Care Symposium 2012 (6)
  • Diabetes Care Symposium 2013 (5)
  • Diabetes Care Symposium 2014 (4)
  • Diabetes Care Symposium 2015 (4)
  • Diabetes Care Symposium 2016 (6)
  • Diabetes Care Symposium 2017 (1)
  • Diabetes Care Symposium 2018 (3)
  • Diabetes Care Symposium 2019 (3)
  • Diabetes Care Symposium 2020 (1)
  • Diabetes Education (123)
  • Diabetes Symposium 2017 (3)
  • Diabetes Symposium 2018 (2)
  • Diabetes Symposium 2019 (2)
  • Diabetes Symposium 2020 (3)
  • Diabetic Dyslipidemia (19)
  • Economic Costs of Diabetes (16)
  • Emergency Preparedness and Lessons Learned (4)
  • Emerging Science and Concepts for Management of Diabetes and Aging (12)
  • Emerging Science, Concepts, and Approach to Precision Medicine (10)
  • Epidemiology-Aging (30)
  • Epidemiology-Cardiovascular Disease (148)
  • Epidemiology-Clinical-Diagnosis and Screening (80)
  • Epidemiology-Diabetes Complications (181)
  • Epidemiology-Nutrition (65)
  • Epidemiology-Other (230)
  • Epidemiology-Type 1 Diabetes (67)
  • Evolving Tactics With Inhibition of Sodium-Glucose Cotransporters (12)
  • Exercise (54)
  • Foot Care-Lower Extremities (55)
  • Genetics-Type 1 Diabetes (36)
  • Genetics-Type 2 Diabetes (61)
  • Guiding Principles for Diabetes Care (5)
  • Health Care Delivery-Economics (106)
  • Heart Failure (6)
  • IDF-ADA Translational Symposium (5)
  • Immunology (88)
  • Insulin Action-Adipocyte Biology (23)
  • Insulin Action-Cellular and Molecular Metabolism (20)
  • Insulin Action-Glucose Transport and Insulin Resistance In Vitro (3)
  • Insulin Action-Signal Transduction, Insulin, and Other Hormones (16)
  • Insulin After More Than 90 Years (13)
  • Integrated Physiology-Central Nervous System Regulation of Metabolism (30)
  • Integrated Physiology-Insulin Secretion In Vivo (26)
  • Integrated Physiology-Liver (53)
  • Integrated Physiology-Macronutrient Metabolism and Food Intake (11)
  • Integrated Physiology-Muscle (23)
  • Integrated Physiology-Other Hormones (54)
  • Islet Biology-Apoptosis (22)
  • Islet Biology-Beta Cell-Development and Postnatal Growth (42)
  • Islet Biology-Beta Cell-Stimulus-Secretion Coupling and Metabolism (51)
  • Islet Biology-Signal Transduction (19)
  • Metabolic Surgery and the Changing Landscape for Diabetes Care (12)
  • Nonalcoholic Fatty Liver Disease in Diabetes (6)
  • Nutrition-Clinical (55)
  • Obesity-Animal (60)
  • Obesity-Human (74)
  • Pediatrics-Obesity and Type 2 Diabetes (29)
  • Pediatrics-Type 1 Diabetes (53)
  • Pregnancy-Basic Science/Translational (15)
  • Pregnancy-Clinical/Epidemiology (92)
  • Profiles in Progress (29)
  • Psychosocial Research and Care in Diabetes (10)
  • Psychosocial, Behavioral Medicine (101)
  • Quality Improvement Success Stories (43)
  • Reconsidering Pregnancy with Diabetes (10)
  • Small Noncoding RNAs in Diabetes (2)
  • The Artificial Pancreas in 2016 (9)
  • The Changing Face of the Type 2 Diabetes Epidemic (9)
  • The RISE Consortium (13)
  • Therapeutic Inertia (17)
  • Transplantation (16)
  • Type 1 Diabetes at a Crossroads (9)
  • Understanding and Addressing Health Disparities in Diabetes Care and Research (7)
  • Renal Disease in Type 1 Diabetes (4)

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.